Arkolith/Insider Trading/PRME/Form 4

Marrazzo Jeffrey D

DirectorPrime Medicine, Inc. (PRME) · full profile →Form 4 · filed Aug 5, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
0 non-derivative · 6 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 1, 2025Disposed to issuer(D)45K——0
Aug 1, 2025Grant(A)45K——45K
Aug 1, 2025Disposed to issuer(D)250K——0
Aug 1, 2025Disposed to issuer(D)92K——0
Aug 1, 2025Grant(A)92K——92K
Aug 1, 2025Grant(A)250K——250K

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001894562-25-000048) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML